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Background: Studies on major depressive and anxiety disorders suggest dysfunctions in brain corticolimbic circuits,
including altered gamma-aminobutyric acid (GABA) and modulatory (serotonin and dopamine) neurotransmission.
Interestingly, sexual dimorphisms in GABA, serotonin, and dopamine systems are also reported. Understanding the
mechanisms behind these sexual dimorphisms may help unravel the biological bases of the heightened female
vulnerability to mood disorders. Here, we investigate the contribution of sex-related factors (sex chromosome
complement, developmental gonadal sex, or adult circulating hormones) to frontal cortex expression of selected
GABA-, serotonin-, and dopamine-related genes.
Methods: As gonadal sex is determined by sex chromosome complement, the role of sex chromosomes cannot be
investigated individually in humans. Therefore, we used the Four Core Genotypes (FCG) mouse model, in which sex
chromosome complement and gonadal sex are artificially decoupled, to examine the expression of 13 GABA-related
genes, 6 serotonin- and dopamine-related genes, and 8 associated signal transduction genes under chronic stress
conditions. Results were analyzed by three-way ANOVA (sex chromosome complement × gonadal sex × circulating
testosterone). A global perspective of gene expression changes was provided by heatmap representation and gene
co-expression networks to identify patterns of transcriptional activities related to each main factor.
Results: We show that under chronic stress conditions, sex chromosome complement influenced GABA/serotonin/
dopamine-related gene expression in the frontal cortex, with XY mice consistently having lower gene expression
compared to XX mice. Gonadal sex and circulating testosterone exhibited less pronounced, more complex, and
variable control over gene expression. Across factors, male conditions were associated with a tightly co-expressed set
of signal transduction genes.
Conclusions: Under chronic stress conditions, sex-related factors differentially influence expression of genes linked to
mood regulation in the frontal cortex. The main factor influencing expression of GABA-, serotonin-, and dopamine-related
genes was sex chromosome complement, with an unexpected pro-disease effect in XY mice relative to XX mice. This
effect was partially opposed by gonadal sex and circulating testosterone, although all three factors influenced signal
transduction pathways in males. Since GABA, serotonin, and dopamine changes are also observed in other psychiatric
and neurodegenerative disorders, these findings have broader implications for the understanding of sexual dimorphism
in adult psychopathology.
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Major depressive disorder (MDD) is a common, chronic
illness characterized by low mood, sadness, or irritability
along with psychophysiological changes, ultimately inter-
fering with family relations and normal daily activities
[1]. Affecting approximately 14.8 million adults in the
USA, MDD is twice as common in women as in men,
with the lifetime incidence of MDD being 20% in
women and 12% in men [1]. In addition to sex dif-
ferences in prevalence and incidence of MDD, women
have a higher morbidity risk than men [2]. Notably,
community-based epidemiologic studies also report in-
creased female prevalence of MDD [3]. Thus, these stud-
ies observe sex differences in MDD after controlling for
the potential confounding variable of seeking treatment,
suggesting underlying predisposing biological factors in
females.
GABA dysfunction in MDD
Studies suggest dysfunction of corticolimbic circuits and
dysregulation in gamma-aminobutyric acid (GABA) neuro-
transmission in MDD. Magnetic resonance spectroscopy
[4-6] and molecular [7,8] studies have directly reported
decreased GABA content in MDD or suggested reduced
GABA-mediated inhibition (reviewed in [9]). Our group
recently reported reduced markers of dendritic-targeting
GABA interneurons in the amygdala [8], subgenual anterior
cingulate cortex (sgACC) [10,11], and dorsolateral pre-
frontal cortex (dlPFC) [12] of MDD patients, specifically
affecting somatostatin (SST), the most common marker
of dendritic-targeting interneurons. Interestingly, these
findings were more robust in females with depression
[10,11,13]. These human findings are supported by causal
studies in mice, where mild reduction in GABA signaling is
sufficient to induce depressive-like behaviors [14], together
supporting a GABA deficit hypothesis of MDD [9]. We
recently examined expression of Sst, and of the GABA-
synthesizing enzymes glutamate decarboxylase 67 (Gad67)
and Gad65, in the frontal cortex of Four Core Genotypes
(FCG) mice in order to independently examine the contri-
bution of developmental gonadal sex (organizational), adult
circulating hormones (activational), and X/Y sex chromo-
some complement on expression of those genes under
rodent conditions that are homologous to a human de-
pressed state, i.e., after exposure to unpredictable chronic
mild stress. Contrary to our prediction based on increased
MDD prevalence in women, regardless of gonadal and
adult hormonal status, FCG XY mice (i.e., genetic males
that lack the sex-determining gene Sry on the Y chromo-
some; see ‘Methods’) had lower expression of these three
genes compared to XX mice, with concomitant elevated
anxiety-like behavior; interestingly, adult testosterone treat-
ment decreased anxiety-like behaviors, but did not affect
Sst, Gad67, or Gad65 gene expression [13]. Together, thesestudies in humans and mice support a general hypothesis
of GABA dysfunction in MDD and point to sex chromo-
some complement as a potential modulator.
Serotonin and dopamine in MDD
Along with evidence for dysfunction in fast-acting
GABA neurotransmission in MDD, evidence also sug-
gests problems with slow-acting neuromodulatory sys-
tems (e.g., serotonin and dopamine). Evidence for
involvement of serotonin in MDD includes decreased
tryptophan [15] and decreased serotonin metabolites
[16] in the cerebrospinal fluid (CSF) of depressed pa-
tients and altered markers of transmission in the frontal
cortex and of midbrain factors involved in serotonin
production, suggesting ineffective subcortical-cortical
serotonergic transmission [17]. Studies in rodents have
extensively probed the link between the serotonin
system and anxiety/depressive-like behaviors [18,19],
and sex differences in the serotonin system have been
reported in humans and rodents (e.g., [20-22]). Imaging
and postmortem studies of the dopamine system in
MDD suggest changes in receptor levels but are overall
more equivocal [23-25]. Recent optogenetic studies sug-
gest a causal link between ventral tegmental area (VTA)
dopaminergic neuron firing and anhedonia-like behav-
ior in mice [26]. Imaging studies in humans report
dopamine-related sexual dimorphism in the frontal cor-
tex of control subjects, with increased dopamine D2-like
receptors in women compared to men [27]. Sex differ-
ences in dopamine have been extensively studied in
rodents and report, for instance, lower dopamine levels
and higher turnover in the frontal cortex of female com-
pared to male rats [28].
Biological sex factors
Taking into consideration potential hormonal mecha-
nisms underlying observed sexual dimorphism, circulat-
ing gonadal hormones have acute, transient effects
throughout life (activational hormone effects), while
exposure to gonadal hormones during critical periods
of development can cause permanent sex differences
(organizational hormone effects). The organizational
actions of gonadal hormones have long been known to
cause sex differences in behavior and brain structure,
although the majority of studies involve sex behavior
and regions controlling sex behavior in rodents (e.g.,
[29,30]). Evidence from human studies suggests an asso-
ciation between low testosterone levels and anxiety and
depression susceptibility, suggesting activational effects
of testosterone on mood. For instance, a prospective
study following men over 50 with low or normal levels
of testosterone found that men with low testosterone
had increased risk of developing depression [31]. An-
other study found lower testosterone levels in depressed
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Interestingly, evidence also suggests an association of tes-
tosterone levels with anxiety and depression in women
and that SSRIs may increase testosterone levels in both
men and women [33]. An additional mechanism under-
lying sexual dimorphism is sex chromosome complement;
Y chromosome gene or X chromosome gene dosage could
play a role in sexual dimorphism (reviewed in [34]). Sex
chromosome complement has a predominant role during
development in determining gonadal sex, but contri-
butions of X/Y genes are ongoing throughout life. It is
impossible to separate the role of sex chromosomes from
gonadal sex in traditional wild-type mice, regardless of
hormone manipulation. However, genetic manipulation
was used to engineer the FCG mice, in which the testes-
determining gene Sry was placed on an autosome after
spontaneous deletion from the Y chromosome, thus dis-
sociating sex chromosome complement from gonadal sex.
In addition to our studies in the FCG mice detailed above,
other studies in FCG mice have revealed sex chromosome
influences on sexual differentiation of aggressive, parental,
and social behaviors [35-37] and vasopressin innervation
in the lateral septum [38].
Evidence suggests both dysregulation in human mood-
related disorders affecting the GABA, serotonin, and
dopamine systems in MDD and sexual dimorphism in
these systems across species; however, the underlying
causes for these sex differences remain unclear. Here, we
used the FCG mice to probe frontal cortex expression of
selected genes in the GABA, serotonin, and dopamine
systems for evidence of sexual dimorphism and to inves-
tigate the putative sex-related origins of observed sex
differences, with the goal of gaining insight into the bio-
logical basis of the sexual dimorphism of MDD and anx-
iety disorders. Since we are interested in identifying
genes that may vary by sex in the context of mood disor-
ders, we investigated FCG mice exposed to unpredict-
able chronic mild stress (UCMS). This model replicates
the role of stress in eliciting physiological and behavioral
changes that are homologous to a depressive-like syn-
drome in mice and respects the time frame of onset and
efficacy of antidepressant treatment [39]. Based on the
female prevalence of these mood disorders, we predicted
that gene expression would be affected in pro-disease direc-
tions in the ‘female’ phenotypes (XX mice, gonadal females,
and mice not treated with testosterone in adulthood).
Methods
Mice
FCG mice were used in these studies (Jackson Laborator-
ies, Bar Harbor, ME, USA; B6.Cg-Tg(Sry)2Ei Srydl1Rlb/
ArnoJ). By crossing a C57BL/6 J female with an XY−Sry
male (Y− denotes absence of Sry on the Y chromosome;
Sry denotes presence of the autosomal Sry transgene), fourgroups of mice are generated: XX males (XXSry), XX
females (XX), XY− males (XY−Sry), and XY− females (XY−).
The mice were maintained under standard conditions of
12-h light and dark cycles (22°C ± 1°C, food and water
ad libitum), in accordance with the University of Pittsburgh
Institutional Animal Care and Use Committee. The num-
bers of mice investigated per group are indicated at the
base of the bars in the figures.
These mice were used in a previous study investigating
the effects of UCMS exposure on anxiety- and depressive-
like behaviors in FCG mice [13]. All mice used here for
gene expression analyses were sacrificed after chronic stress
exposure. FCG mice were bilaterally gonadectomized at
15 weeks of age to remove endogenous sources of gonadal
hormones and implanted with either a testosterone-filled
(5-mm crystalline testosterone; 1.57-mm ID× 2.41-mm
OD) or similarly sized blank SILASTIC capsule (Dow
Corning Corp., Midland, MI, USA). This size testosterone
capsule yields circulating testosterone levels at or slightly
above normal male levels (N. Ghahremani, personal
communication). At the time of sacrifice, we collected trunk
blood for testosterone assay to confirm the efficacy of our
adult hormone manipulation. Serum samples were sent
to the University of Virginia Center for Research in
Reproduction LigandAssay andAnalysis Core (supported by
the Eunice Kennedy Shriver NICHD/HIH (SCCPIR) Grant
U54-HD28934), and a radio-immuno assay (RIA) was used
to determine testosterone concentration. A three-way ana-
lysis of variance (ANOVA) revealed that serum testosterone
levels did not differ by sex chromosome complement (XX,
1,026.2 ± 405.2; XY−, 886.2 ± 647.2; p > 0.75) or gonadal sex
(gonadal females, 471.0 ± 238.9; gonadal males, 1,453.6 ±
690.6; p > 0.15), but did differ by hormone manipulation
(blank-treated, 225.8 ± 140.8; testosterone-treated, 1648.9 ±
687.1; p < 0.05).
Unpredictable chronic mild stress
UCMS is a behavioral paradigm that robustly increases
behavioral emotionality, thus presenting some homolo-
gous features associated with human depression (although
not ‘modeling’ this complex human disorder, but provid-
ing critical information about the system under chronic
stress conditions) [40]. The UCMS protocol consisted of
a 7-week period during which group-housed mice were
exposed to a randomized schedule of environmental
stressors approximately one to two times per day, 7 days
a week, as applied in our lab [39,41,42]. Disturbances
included forced bath (approximately 2 cm of water for
15 min), aversive smell (1 h of exposure to bobcat urine),
light cycle reversal or disruption, social stress (rotate mice
into previously occupied cages), tilted cage (45° tilt), mild
restraint (50-ml conical tube with air hole for 15 min),
bedding change (replace soiled bedding with clean bed-
ding), wet bedding, and no bedding. Weekly assessment of
Seney et al. Biology of Sex Differences 2013, 4:20 Page 4 of 18
http://www.bsd-journal.com/content/4/1/20weight and fur was performed to track progression of
the UCMS syndrome (as in [39]). After 7 weeks of UCMS
exposure, mice were run through a series of behavior tests
to assess anxiety/depressive-like behavior: elevated plus
maze, open field, and sucrose preference [13].
Frontal cortex dissection
At the time of sacrifice, brains from FCG mice were flash
frozen on dry ice (after 7 weeks of UCMS and while still
being exposed to stressors) and stored at −80°C. Rostro-
caudal sections (160 μm thick) were obtained using a cryo-
stat, and a 1-mm-bore tissue punch was used to isolate
the bilateral frontal cortex (cingulate cortex and prelimbic
cortex; between bregma +2.34 and +0.50 mm; [43]).
Gene selection
GABA-related genes
We examined expression of several genes associated with
cortical GABA microcircuitry: (1) markers of dendritic-
targeting interneurons (neuropeptide Y (Npy), cortistatin
(Cst), vasoactive intestinal peptide (Vip)), (2) markers of
perisomatic-targeting GABA neurons (parvalbumin (Pv),
cholecystokinin (Cck)) and other interneuron-targeting in-
terneurons (calretinin (Cr)), (3) other GABA-related genes
(GABA A receptor subunits (Gabra1, Gabra2, Gabra5)
and the GABA transporter (Gat1)), and (4) two brain-
derived neurotrophic factor (BDNF)-related genes (Bdnf
and its receptor,Trkb), based on previous results indicating
BDNF control of GABA-related gene expression [8,11].
Serotonin- and dopamine-related genes
Expression of serotonin- and dopamine-related genes
was examined in the Allen Brain Atlas. Genes with high
frontal cortex expression were selected for quantitative
polymerase chain reaction (qPCR) analysis. We examined
expression of (1) serotonin and dopamine receptors
(Drd1a, Htr1a, Htr2a, Htr2c), (2) associated signal trans-
duction pathway components (adenylate cyclase 1 (Adcy1),
Adcy2, Adcy5, Adcy7, cyclin-dependent kinase 5 (Cdk5),
Akt1, Akt2, Akt3), and (3) related genes with prior evidence
for sex differences (amyloid precursor protein (App) prody-
norphin (Pdny) [44]).
Real-time quantitative PCR
Total RNA was extracted from tissue punches using the
Allprep® DNA/RNA Micro Kit (Qiagen, Valencia, CA,
USA) and assessed by chromatography (Agilent Bioana-
lyzer, Santa Clara, CA, USA). RIN was 8.35 ± 0.04 (mean ±
standard error of the mean (SEM)), indicating excel-
lent RNA quality. Total RNA (100 ng) was reverse-
transcribed into cDNA using QScript cDNA Supermix
(oligo(dT) and random primers, Quanta Biosciences,
Gaithersburg, MD, USA). Small PCR products (70–
100 bp) were amplified on a Mastercycler® ep Realplex2qPCR machine (Eppendorf, Hamburg, Germany) using
universal PCR conditions (65°C to 59°C touch-down and
40 cycles (10 s at 95°C, 10 s at 59°C, and 10 s at 72°C)).
cDNA was amplified in 15-μl reactions (0.1 × SYBR
Green, 3 mM MgCl2, 200 nM dNTPs, 200 nM primers,
0.25 unit Platinum Taq DNA polymerase (Invitrogen,
Carlsbad, CA, USA)). Primer-dimers were assessed by
amplifying primers without cDNA. Primers were retained
if they produced no primer-dimers or non-specific signal
only after 35 cycles. Samples were run in quadruplicate
and results were calculated as the geometric mean of rela-
tive intensities compared to two internal controls (actin
and glyceraldehyde-3-phosphate dehydrogenase; these in-
ternal controls were not influenced by sex-related factors
in our dataset). Results are expressed as arbitrary signal
(2−dCT × 10,000) [45].
Statistical analysis of gene expression results
We used a full three-way ANOVA (sex chromosome
complement × developmental gonadal sex × circulating
hormone with all three first-order interaction and one
second-order interaction terms) to compare groups for
gene expression. This same approach to analyzing effects
of sex-related factors has been previously used for FCG
mice (e.g., [46-48]). Developmental gonadal sex effects
were analyzed by comparing mice with ovaries to those
with testes; since all mice were gonadectomized approxi-
mately 10 weeks prior to sacrifice, any gene expression
differences observed due to gonads are considered to be
organizational effects (permanent changes due to hor-
mone exposure during a critical developmental period).
Activational effects of testosterone were examined by
comparing mice gonadectomized in adulthood and im-
planted with testosterone-filled capsules to those gonad-
ectomized and implanted with blank capsules. If the
three-way ANOVA was significant for any main effect or
interaction, we performed planned contrasts using Tukey's
post hoc test. Data are expressed as mean ± SEM, statistical
significance was set at p < 0.05, and trend level was set at
p < 0.1. To test for potential type I errors, we controlled
the false discovery rate (set to 5%) using the Benjamini-
Hochberg method [49]; the number of genes in each cat-
egory was used as the total number of tests (13 for
GABA-related genes, 14 for serotonin/dopamine-related
genes). Note that the goal of this study was not to examine
the effect of chronic stress on gene expression, but rather
to investigate the effect of sex-related factors on gene
expression under chronic stress conditions.
Correlation between gene expression and anxiety-like
behavior
Using the Pearson correlation, we compared expression
of each gene examined here as well as for Sst, Gad67,
and Gad65 (reported in [13]) to anxiety-like behavior in
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separately in [13]). In order to reduce the complexity of
this correlational analysis, we combined anxiety-like be-
havior measures from the elevated plus maze (time open
and percent crosses into open arms) and open field
(time center, percent distance center) into anxiety-like
emotionality Z-scores (see detailed methods for behav-
ioral Z-scoring in [50]). Z-scores calculate how many
standard deviations (σ) an observation (X) is above or
below the mean of a control group (μ):
z ¼ X−μ
σ
:
First, we calculated Z-scores for each behavior test
measure (e.g., Z_EPM_TimeOpen or Z_OF_Time Center)
by normalizing an individual's measure to the mean
and standard deviation of the comparison group (XX
blank here). The directionality of scores was adjusted
so that increased score values reflected increased
anxiety-like emotionality. For example, decreased time
in the open arms of the EPM was converted into posi-
tive deviation changes compared to group means, indi-
cating increased anxiety-like emotionality. Second,
each individual's Z-score was calculated within behavior
tests (e.g., Z_EPM) by averaging the Z-scores of the behavior
test measures (e.g., average of Z_EPM_Time Open and
Z_EPM_%CrossesOpen). Third, an overall Z-score (anxiety-
like emotionality) was obtained for each animal by averaging
values across behavioral tests (e.g., average of Z_EPM and
Z_OF). A graph showing effects of sex-related factors on
anxiety-like emotionality Z-scores is included in Additional
file 1: Figure S1. The overall Z-anxiety score for each animal
could then be compared to gene expression using the
Pearson correlation. The Benjamini-Hochberg method [49]
was used with 5% false discovery rate; correlations were
performed separately for GABA-related genes and sero-
tonin/dopamine-related genes, and we controlled for the
number of genes in each category (16 and 14, respectively).
Heatmap visualization of gene expression results
We used the matrix2png online software to create expres-
sion heatmaps [51] for genes investigated and also for Sst,
Gad67, and Gad65 (reported in [13]). Expression for each
main factor was expressed as the ‘male’ phenotype divided
by the female phenotype (i.e., sex chromosome comple-
ment, XY−/XX; gonadal sex, testes/ovaries; activational,
testosterone/blank). If expression of a gene was higher in
the male phenotype, the heatmap codes the color as red; if
expression of a gene was higher in the female phenotype,
the heatmap codes the color as blue.
Gene network analysis
As was performed for heatmap visualization of gene ex-
pression results, we included expression values for Sst,Gad67, and Gad65 (reported in [13]). The correlation
strength was measured using the Pearson correlation co-
efficient raised by power 3 (i.e., |r|3) so as to enhance
the signal from high correlation while penalizing those
small correlations which could be introduced by random
noise. Global graph properties are measured by density,
clustering coefficient, and assortativity. Density measures
how many edges are present in a network compared to
the maximum possible number of edges:
Density ¼ mean kið Þ= n−1ð Þ
where ki denotes the connectivity of node i.
Global clustering coefficient measures the extent to
which nodes in a network tend to cluster together. When
a node has n neighbors, there are at most n(n − 1) / 2
edges that can exist between them (when every neighbor
of the node is connected to every other neighbor). The
local clustering coefficient of this node indicates the frac-
tion of allowable edges that exist [52], and it is calculated
as below in the context of the weighted network:
ClusterCoef i
∑j≠i∑k≠i;jwijwjkwki
∑j≠iwij
 2−∑j≠i wij 2
wij represents the weight of edge between nodes i and j
and the global clustering coefficient is calculated by aver-
aging the local clustering coefficients for all nodes in the
network.
Assortativity quantifies the likelihood that an edge will
connect two nodes of similar degree, in other words, a
preference for high-degree nodes to be connected to
other high-degree nodes (here, the assortativity measure
would be greater than 0). If a network has disassortativ-
ity (the assortativity measure is less than 0), high-degree
nodes are more likely to be connected to low-degree
nodes [53]. The assortativity value r for a network with M
edges, connecting nodes of degrees j and k, is defined as
r ¼
M−1∑mi¼1 jiki− M
−1∑mi¼1
1
2
ji þ ki
  2
M−1∑mi¼1
1
2
j2i þ k2i
 
− M−1∑mi¼1
1
2
ji þ ki
  2
To compare global network properties between net-
works, the p value is calculated by randomly assigning
mice to groups and determining how often the global
graph properties between the two groups differ by
chance; the permutation is repeated 1,000 times. These
graph measures were calculated using igraph package
from R CRAN. Paired networks for each main effect
were visualized by the graphical software Cytoscape.
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Effects of sex-related factors on GABA-related genes
Refer to Table 1 for summary of statistical results and
Additional file 2: Figure S2 for graphical representa-
tions of all GABA-related genes separated into all
eight experimental groups. Note that we examined
gene expression in all mice under chronic stress
conditions.
Markers of dendritic-targeting GABA interneurons
We observed an effect of sex chromosome complement on
expression of Vip and Calb1, with lower expression of both
genes in XY− mice (Figure 1A). There was also a main
effect of circulating testosterone on Calb1 (Figure 1A) and
an interaction of gonadal sex and circulating testosterone
(Figure 1B); testosterone exposure decreased Calb1 expres-
sion only in gonadal females. There was a significant inter-
action of gonadal sex and circulating testosterone on
expression of Cst (Figure 1B). Post hoc analysis revealed
an intricate picture of how organizational and activationalTable 1 Statistical values associated with GABA-related gene
Gene Sex chromosome
Dendritic-targeting GABA
interneuron markers
Vip F = 4.91; df = 1;
p < 0.03
Calb1 F = 6.66; df = 1;
p < 0.015
Cst F = 1.51; df = 1;
p > 0.20
Npy F = 1.11; df = 1;
p > 0.29
Soma/interneuron-targeting
GABA interneuron markers
Cr F = 0.99; df = 1;
p > 0.32
Cck F = 3.31; df = 1;
p < 0.08
Pv F = 0.14; df = 1;
p > 0.70
GABA-related genes Gat1 F = 9.23; df = 1;
p < 0.005
Gabra1 F = 0.13; df = 1;
p > 70
Gabra2 F = 0.38; df = 1;
p > 0.50
Gabra5 F = 0.02; df = 1;
p > 0.90
BDNF-related genes Bdnf F = 0.40; df = 1;
p > 0.50
Trkb F = 8.27; df = 1;
p = 0.005
Numbers in bold indicate comparisons that were significant at 5% false discovery reffects of hormones affect Cst expression: (1) mice with
ovaries during development and testosterone-treated in
adulthood had higher Cst levels than blank-treated mice;
(2) when gonadal males and females were treated with
blank capsules after gonadectomy, gonadal males had
higher Cst expression; and conversely, (3) when gonadal
males and females were testosterone-treated, gonadal fe-
males had higher Cst expression. There were no effects of
sex-related factors on Npy gene expression.
Markers of soma/interneuron-targeting GABA interneurons
We found that sex-related factors had no effect on ex-
pression of Cr, Cck, or Pv.
Other GABA-related genes
We found a significant effect of sex chromosome com-
plement on expression of Gat1 (Figure 1A), with lower
expression in XY− mice. There were no significant ef-
fects of sex-related factors on expression of the GABA A
subunits, Gabra1, Gabra2, or Gabra5.expression in the frontal cortex of FCG mice
Gonadal sex Activational Significant interactions
F = 0.32; df = 1; F = 0.57; df = 1;
p > 0.50 p > 0.45
F = 0.02; df = 1; F = 8.22; df = 1; Gonadal × Activational:
p > 0.80 p = 0.005 F = 9.09; df = 3; p < 0.005
F = 0.001; df = 1; F = 3.26; df = 1; Gonadal × Activational:
p > 0.95 p < 0.10 F = 8.625; df = 3; p < 0.005
F = 0.51; df = 1; F = 1.93; df = 1;
p > 0.45 p > 0.15
F = 0.26; df = 1; F = 1.58; df = 1;
p > 0.62 p > 0.20
F = 0.53; df = 1; F = 0.71; df = 1;
p > 0.45 p > 0.40
F = 0.01; df = 1; F = 0.15; df = 1;
p > 0.90 p > 0.65
F = 1.45; df = 1; F = 2.33; df = 1
p > 0.20 p > 0.1
F = 0.44; df = 1; F = 0.56; df = 1;
p > 0.50 p > 0.45
F = 0.003; df = 1; F = 0.64; df = 1;
p > 0.95 p > 0.40
F = 0.77; df = 1; F = 3.47; df = 1;
p > 0.35 p < 0.1
F = 0.01; df = 1; F = 1.72; df = 1; Gonadal × Activational:
p > 0.90 p > 0.15 F = 4.84; df = 3; p < 0.04
F = 0.18; df = 1; F = 1.62; df = 1;
p > 0.60 p > 0.20
ate with correction for the 13 genes examined.
Figure 1 Effects of sex-related factors on expression of
GABA-related genes. (A) GABA-related genes exhibiting significant
main effects of sex chromosome complement (Vip, Calb1, Gat1, Trkb),
gonadal sex (none), and/or circulating testosterone (Calb1). (B)
GABA-related genes with significant interactions of sex-related
factors. There was a significant interaction of gonadal sex and
circulating testosterone on expression of Cst, Calb1, and Bdnf. Numbers
at the base of bars indicate N. ***p < 0.001, **p < 0.01, *p < 0.05;
T testosterone, B blank, F gonadal female, M gonadal male.
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There was a main effect of sex chromosome complement
on expression of the BDNF receptor Trkb (Figure 1A), with
lower expression in XY− mice. We observed no main effects
on Bdnf expression, but there was a significant interaction
of gonadal sex and circulating testosterone (Figure 1B);
gonadal females treated in adulthood with blank had higher
Bdnf levels compared to those treated with testosterone.We controlled the false positive rate using the Benjamini-
Hochberg method [49] and corrected for the number of
GABA-related genes examined. At 5% false discovery rate,
there was a significant effect of genetic sex on Calb1, Gat1,
and Trkb expression, an effect of circulating testosterone
on Calb1 expression, and interactions between gonadal sex
and circulating testosterone on Calb1 and Cst expression.
These findings suggest that sex chromosome complement
is the main factor influencing expression of the GABA-
related genes examined in the frontal cortex under condi-
tions of chronic stress exposure. Based on findings in
humans indicating reduced expression of GABA-related
genes in MDD [8,10-12] and on genetic manipulations in
mice [54], results were in a direction suggesting that XY−
mice would be more vulnerable to elevated anxiety/depres-
sive-like behavior.
Effects of sex-related factors on serotonin- and
dopamine-related genes
Refer to Table 2 for summary of statistical results and
Additional file 3: Figure S3 for graphical representations
of all serotonin- and dopamine-related genes separated
into all eight experimental groups. Note that we exam-
ined gene expression in all mice under chronic stress
conditions.
Serotonin and dopamine receptors
There was a main effect of sex chromosome complement
on Htr2c, with lower expression in XY− compared to XX
mice (Figure 2A). There was a main effect of gonadal sex
on expression of Htr2a, with higher expression in gonadal
females compared to gonadal males (Figure 2A). There were
main effects of sex chromosome complement (XY− <XX)
and circulating testosterone (testosterone > blank) on Htr1a
expression (Figure 2A) and a significant interaction of circu-
lating testosterone and gonadal sex. Circulating testosterone
caused a decrease in Htr1a expression in gonadal males, but
not gonadal females, and when both gonadal males and
females were treated with testosterone, Htr1a expression
was lower in the gonadal males (Figure 2B). For Drd1a,
there was a main effect of sex chromosome complement
(XY− <XX; Figure 2A) and a significant interaction of circu-
lating testosterone and gonadal sex. Circulating testosterone
increased Drd1a expression in gonadal females, but de-
creased expression in gonadal males; additionally, when both
gonadal males and females were treated with testosterone,
Drd1a expression was lower in gonadal males (Figure 2B).
Signal transduction-related genes
cAMP/PKA pathway For Adcy1, there was a main ef-
fect of gonadal sex (ovaries > testes; Figure 2A), a signifi-
cant interaction of sex chromosome complement and
circulating testosterone (circulating testosterone lowered
Adcy1 expression in XY−, but not XX mice; Figure 2B),
Table 2 Statistical values associated with serotonin- and dopamine-related gene expression in the frontal cortex
Gene Sex chromosome Gonadal sex Activational Significant interactions
Serotonin and
dopamine receptors
Htr1a F = 4.77; df = 1; F = 3.65; df = 1; F = 20.58; df = 1; Gonadal × Activational:
p < 0.04 p < 0.10 p < 0.001 F = 11.92; df = 3; p < 0.001
Htr2a F = 0.22; df = 1; F = 4.32; df = 1; F = 0.11; df = 1;
p > 0.60 p = 0.040 p > 0.70
Htr2c F = 6.29; df = 1; F = 2.16; df = 1; F = 1.88; df = 1;
p < 0.02 p > 0.10 p > 0.15
Drd1a F = 4.01; df = 1; F = 0.049; df = 1; F = 0.13; df = 1; Gonadal × Activational:
p < 0.05 p > 0.80 p > 0.70 F = 2.86; df = 3; p < 0.045
cAMP/PKA pathway Adcy1 F = 1.28; df = 1; F = 4.59; df = 1; F = 0.55; df = 1; Sex chromosome × Activational:
p > 0.25 p < 0.04 p > 0.45 F = 2.70; df = 3; p < 0.05
Sex chromosome × Gonadal × Activational:
F = 2.94; df = 7; p < 0.01
Adcy2 F = 3.32; df = 1; F = 2.35; df = 1; F = 8.83; df = 1;
p = 0.071 p > 0.10 p < 0.005
Adcy5 F = 5.73; df = 1; F = 2.94; df = 1; F = 0.062; df = 1; Genetic × Activational:
p < 0.02 p = 0.089 p > 0.75 F = 2.68; df = 3; p = 0.11
Gonadal × Activational:
F = 3.63; df = 3; p < 0.02
Adcy7 F = 5.37; df = 1; F = 0.94; df = 1; F = 0.08; df = 1;
p < 0.025 p > 0.30 p > 0.75
Cdk5 F = 2.93; df = 1; F = 1.01; df = 1; F = 2.90; df = 1; Gonadal × Activational:
p = 0.09 p > 0.30 p = 0.091 F = 2.67; df = 3; p = 0.051
AKT pathway Akt1 F = 3.75; df = 1; F = 0.61; df = 1; F = 5.99; df = 1; Sex chromosome × Gonadal:
p = 0.056 p > 0.40 p < 0.02 F =2.53; df = 3; p = 0.11
Sex chromosome × Activational:
F = 4.82; df = 3; p < 0.005
Gonadal × Activational:
F = 4.16; df = 7; p < 0.01
Akt2 F = 0.89; df = 1; F = 4.64; df = 1; F = 2.10; df = 1;
p > 0.30 p < 0.035 p > 0.10
Akt3 F = 3.57; df = 1; F = 7.16; df = 1; F = 4.72; df = 1; Sex chromosome × Activational:
p = 0.062 p < 0.01 p < 0.035 F = 2.64; df = 3; p = 0.11
Gonadal × Activational:
F = 6.53; df = 3; p < 0.001
Other serotonin- and
dopamine-related genes
App F = 6.56; df = 1; F = 1.43; df = 1; F = 0.22; df = 1; Gonadal × Activational:
p < 0.015 p > 0.20 p > 0.60 F = 2.17; df = 3; p = 0.096
Sex chromosome × Gonadal ×
Activational: F = 2.62; df = 7; p = 0.11
Pdyn F = 0.29; df = 1; F = 0.38; df = 1; F = 2.09; df = 1;
p > 0.55 p > 0.50 p > 0.15
Numbers in bold indicate comparisons that were significant at 5% false discovery rate with correction for the 14 genes examined. cAMP cyclic adenosine
monophosphate, PKA protein kinase A.
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tors. Circulating testosterone increased Adcy1 expression
in XX gonadal females and decreased Adcy1 expression in
XX gonadal males; there was no effect of testosterone inXY− gonadal females or males (Figure 2B). There was a
main effect of circulating testosterone on Adcy2 expres-
sion, with circulating testosterone causing a decrease in
Adcy2 expression (Figure 2A). For Adcy5, there was a
Figure 2 Effects of sex-related factors on expression of serotonin (5HT)- and dopamine (DA)-related genes. (A) 5HT- and DA-related
genes exhibiting significant main effects of sex chromosome complement (Htr1a, Htr2c, Drd1a, Adcy1, Adcy2, Adcy5, Adcy7, Akt1, Akt3, App),
gonadal sex (Htr1a, Htr2a, Adcy1, Adcy5, Akt2, Akt3), and/or circulating testosterone (Htr1a, Adcy2, Akt1, Akt3). (B) 5HT- and DA-related genes with
significant interactions of gonadal sex and circulating testosterone (Htr1a, Drd1a, Adcy5, Akt1, Akt3), sex chromosome complement and circulating
testosterone (Adcy1, Akt1), or interaction of all three sex-related factors (Adcy1). Numbers at the base of bars indicate N. ***p < 0.001, **p < 0.01,
*p < 0.05, #p < 0.1; T testosterone, B blank, F gonadal female, M gonadal male.
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Figure 2A) and a significant interaction of circulating tes-
tosterone and gonadal sex. Circulating testosterone in-
creased Adcy5 expression in gonadal females, but not
gonadal males, and when both gonadal males and females
were treated with testosterone, Adcy5 was lower in go-
nadal males (Figure 2B). There was a main effect of sex
chromosome complement on Adcy7 expression, with
lower expression in XY− mice (Figure 2A). There were no
main effects on Cdk5 expression; however, there was a
trend for an interaction between circulating testosterone
and gonadal sex. Testosterone decreased Cdk5 expression
in gonadal males only, and when gonadal males and fe-
males were treated with testosterone, Cdk5 expression was
lower in gonadal males (Figure 2B).AKT pathway-related genes For Akt1, there was a
main effect of circulating testosterone on expression
(Figure 2A) and interactions between sex chromosome
complement and circulating testosterone as well as be-
tween gonadal sex and circulating testosterone. Testos-
terone decreased Akt1 expression in XY−, but not XX
mice; when XX and XY− mice were both treated with
testosterone, Akt1 expression was lower in XY− mice
(Figure 2B). Additionally, testosterone decreased Akt1
expression in gonadal males, but not gonadal females;
when gonadal males and females were treated with tes-
tosterone, Akt1 expression was lower in gonadal males
(Figure 2B). There was a main effect of gonadal sex on
expression of Akt2, with lower expression in gonadal
males (Figure 2A). For Akt3, there were main effects of
Seney et al. Biology of Sex Differences 2013, 4:20 Page 10 of 18
http://www.bsd-journal.com/content/4/1/20circulating testosterone and gonadal sex (Figure 2A) and
a significant interaction of circulating testosterone and
gonadal sex. Circulating testosterone decreased Akt3
expression only in gonadal males; when both gonadal
males and females were treated with testosterone, Akt3
expression was lower in gonadal males (Figure 2B).
Other serotonin- and dopamine-related genes
There was a main effect of sex chromosome comple-
ment on App expression, with lower expression in XY−
mice (Figure 2A). We found no effects of sex-related fac-
tors on Pdny expression.
All significant results found using uncorrected p values
remained significant after performing a Benjamini-Hochberg
correction [49] at 5% false discovery rate for the number of
serotonin/dopamine-related genes examined. Similar to our
findings for GABA-related genes, sex chromosome com-
plement is the main factor influencing expression of the se-
rotonin/dopamine-related genes examined in the frontal
cortex under conditions of chronic stress exposure. Here,
however, several genes were influenced by the interaction of
gonadal sex and adult circulating testosterone, with testoster-
one treatment causing a decrease in gene expression only in
gonadalmales.
Correlation between gene expression and anxiety-like
behavior
Refer to Table 3 for summary of genes positively or nega-
tively correlated with anxiety-like behavior (after Benjamin-
Hochberg correction and 5% false discovery rate) [49] and
Additional file 4: Table S1 and Additional file 5: Table S2
for statistical values associated with each correlation test.
We first searched for significant correlations betweenTable 3 Genes correlated with anxiety-like behavior
Correlation
(+) correlation with anxiety-like behavior overall
(−) correlation with anxiety-like behavior overall
(+) correlation with anxiety-like behavior in XX
(−) correlation with anxiety-like behavior in XX
(+) correlation with anxiety-like behavior in XY
(−) correlation with anxiety-like behavior in XY
(+) correlation with anxiety-like behavior in gonadal females
(−) correlation with anxiety-like behavior in gonadal females
(+) correlation with anxiety-like behavior in gonadal males
(−) correlation with anxiety-like behavior in gonadal males
(+) correlation with anxiety-like behavior in blank-treated
(−) correlation with anxiety-like behavior in blank-treated
(+) correlation with anxiety-like behavior in T-treated
(−) correlation with anxiety-like behavior in T-treated
Genes with a negative correlation with anxiety-like behavior in gonadal females and
in bold.anxiety-like behavior and gene expression in all mice com-
bined and found that Trkb, Htr2c, Adcy5, and App were
negatively correlated with anxiety-like behavior. We next
examined potential correlations between gene expression
and anxiety-like behavior after splitting mice by each main
sex-related factor (XX, XY, gonadal males, gonadal females,
blank-treated, testosterone-treated) to search for differential
correlation patterns. Interestingly, patterns of correlation
between gene expression and anxiety-like behavior seem to
vary by sex-related factors (i.e., XX versus XY−, gonadal
males versus gonadal females). For instance, while Pdyn is
the only gene positively correlated with anxiety-like behav-
ior in XX mice, Htr1a, Cdk5, Adcy2, Akt1, Akt2, and Akt3
positively correlate with anxiety-like behavior in XY−
mice. Another interesting observation based on this
correlation analysis is that gonadal males and gonadal
females exhibit opposite patterns of correlation for
many genes; while Adcy1, Adcy2, Akt1, and Akt3 are
negatively correlated with anxiety-like behavior in go-
nadal females, these same genes are positively corre-
lated with anxiety-like behavior in gonadal males. The
correlation patterns based on hormone treatment were
fairly week, with only Htr2c and App being negatively
correlated with anxiety-like behavior in testosterone-
treated mice.
Heatmap representation of gene expression
by main sex-related factor in FCG mice
To summarize the qPCR data and extract patterns of
influence for sex-related factors on gene expression, we
visualized results for all genes using a heatmap. We in-
cluded results for three GABA-related genes (Sst, Gad65,
and Gad67) from a previous report using the same miceGenes
None
Trkb, Htr2c, Adcy5, App
Pdyn
Htr2c, Adcy5, App,
Htr1a, Cdk5, Adcy2, Akt1, Akt2, Akt3
None
None
Cst, Drd1a, Htr2c, Adcy1, Adcy2, Adcy5, Adcy7, Akt1, Akt3, App
Htr1a, Adcy1, Adcy2, Cdk5, Akt1, Akt3
None
None
None
None
Htr2c, App
positive correlation with anxiety-like behavior in gonadal males are indicated
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GABA-related, serotonin/dopamine-related, and signal
transduction pathway-related genes, the pattern of re-
duced expression in XY− mice compared to XX was the
most striking feature of the graph (indicated by the blue
color of most genes for the sex chromosome comparison)
(Figure 3). Interestingly, the summarized results for go-
nadal sex suggested an overall pattern of higher expression
of GABA-related genes (shown in red) and lower expres-
sion of serotonin/dopamine-related genes (shown in blue)
in gonadal males (Figure 3). Note that most of these go-
nadal sex comparisons and those for activational effects
did not yield significant results in the ANOVA analysis,
but the pattern of results is still apparent in the heatmap
representation. The results for activational effects of tes-
tosterone were mixed; expression of some genes was
higher in testosterone-treated mice (shown in red), while
other genes had higher expression in blank-treated mice
(shown in blue) (Figure 3). Thus, it appears as though theFigure 3 Heatmap representation of gene expression results. Expressi
the female phenotype (i.e., sex chromosome, XY/XX; gonadal sex, testes/ov
expressed at higher levels in the male phenotype; blue indicates that the g
asterisk indicates significant main effect of that factor; the plus sign indicategeneral effect of male sex chromosome complement to
decrease gene expression is only partially reversed by the
effects of male gonadal sex and circulating testosterone.
Together, these results indicate balancing roles between
sex-related factors, with a potential dominant effect of
male sex chromosome complement against male gonadal
sex and circulating testosterone in controlling GABA/
serotonin/dopamine-related gene expression.
Gene network-based analysis
We next applied co-expression network analyses as an al-
ternative approach to investigate the effects of sex-related
factors on expression patterns. Two genes or transcripts
are considered co-expressed if their patterns of expression
are correlated across samples; this link has been shown to
reflect shared function, through multiple potential bio-
logical pathways, including common regulatory pathways
(e.g., hormone signaling, transcription factors) [55,56].
Weighted gene co-expression networks were constructedon for each main factor is expressed as the male phenotype divided by
aries; activational, testosterone/blank). Red indicates that the gene was
ene was expressed at higher levels in the female phenotype. The
s significant interaction involving that factor.
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XY−, gonadal female versus gonadal male, blank-treated
versus testosterone-treated); nodes represent the genes in-
vestigated and edges represent the correlation magnitude
of gene co-expression. The male phenotype (XY−, gonadal
male, testosterone-treated) was used as the reference
network due to its robust effect on differential expressionFigure 4 Weighted gene co-expression networks of all GABA-, seroto
chromosome complement, gonadal sex, and hormone treatment. Lines con
weight of the line proportional to the level of co-expression. Red lines indic
between genes. The size of each node indicates the degree (sum of the ed
(XY−, gonadal male, testosterone-treated) were used as reference networks
(XX, gonadal female, blank-treated) was plotted on the network structure e(Figure 4), and this structure was applied to the data for
each female phenotype (XY−, gonadal female, blank-
treated). The male network for chromosomal sex and go-
nadal sex exhibited increased assortativity compared to the
associated female networks (p < 0.03 for both comparisons;
Table 4). Notably, the XX and gonadal female networks
exhibit disassortativity (i.e., assortativity measures lessnin-, and dopamine-related genes. Networks are split based on sex
necting genes indicate co-expression of those two genes, with the
ate positive correlation, while blue lines indicate negative correlation
ge weights of all connections) for that gene. The male phenotypes
due to their robust effect on expression, meaning that the female data
stablished by the respective male phenotype.
Table 4 Statistical values associated with global network measures
Global network
property
XX XY Sex chromosome
p value
Gonadal
female
Gonadal
male
Gonadal
sex p value
Blank-
treated
T-treated Activational
p value
Density 0.016 0.022 0.213 0.016 0.022 0.142 0.017 0.022 0.081
Global clustering
coefficient
0.037 0.050 0.334 0.044 0.056 0.297 0.035 0.049 0.213
Assortativity −0.089 0.120 0.025 −0.084 0.124 0.027 −0.062 0.010 0.274
Figure 5 Model representing the dynamic equilibrium
controlling gene expression (i.e., structure) and associated
anxiety-like behaviors (i.e., function). Blue lines indicate decreased
gene expression or anxiety-like behavior and red arrows indicate
increased gene expression or anxiety-like behavior; the brightness of
the color indicates intensity of the effect, with darker shades indi-
cating increased robustness of the effect.
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http://www.bsd-journal.com/content/4/1/20than 0), indicating that in these networks, nodes with high
degree are likely to be connected to nodes with low de-
gree; the XY and gonadal male networks have assortativity
measures greater than 0, indicating that high-degree nodes
are likely to be connected to other high-degree nodes.
Additionally, there was a trend for the male activational
network (i.e., testosterone-treated) to exhibit increased
density compared to the female activational network (p <
0.09; Table 4), indicating that the male activational net-
work has more overall connections between nodes. It is
important to note that the significant differences we see
between networks are not driven by effects of other sex-
related factors. For instance, the XX and XY− networks
both contain gonadal males, gonadal females, mice treated
with blank, and mice treated with testosterone. Therefore,
the only difference between the XX and XY− networks is
the sex chromosomal difference, and we can conclude that
any significant differences we see between networks are
driven by the sex chromosome difference. These statistical
differences between networks were visually reflected in
the male networks having more strong connections be-
tween genes (i.e., high correlation; indicated by thicker lines
connecting genes) compared to the matched female net-
works (Figure 4). Notably, all three male networks (XY−
mice, gonadal males, and testosterone-treated mice) dis-
played a similar tightly linked co-expression module of
signal transduction-related genes with high degree (i.e.,
hubness; indicated by the size of the node) that was not
present in XX mice, gonadal females, or blank-treated mice
(Figure 4). This core module includes Akt1, Akt2, Akt3,
Adcy2, Adcy5, and Pdyn in XY− mice, gonadal males, and
testosterone-treated mice; the core module in XY− mice
and gonadal males also includes Cdk5 and App.
Discussion
Using the FCG mice, we examined the effect of sex
chromosome complement, developmental gonadal sex,
and circulating testosterone on frontal cortex expression
of selected GABA-, serotonin-, and dopamine-related
genes, after exposure to unpredictable chronic mild
stress, as a validated translational model for depressive-
like pathology. Overall, the most robust main effect was
that of sex chromosome complement, which consistently
caused lower gene expression in XY− compared to XX
mice (Figures 1 and 2). While we did see main effects of
gonadal sex and circulating testosterone on geneexpression, they were mostly in the context of interac-
tions between these two main factors (Figures 1 and 2).
Pearson correlation analysis between gene expression
and anxiety-like behavior measures from the same mice
revealed that gene-behavior correlation patterns vary by
sex-related factors (XX versus XY− and gonadal female
versus gonadal male). Heatmap representation of the
data confirmed the general pattern of sex chromosome
complement-mediated decreased expression in XY−
mice (indicated by blue color in Figure 3) that was par-
tially reversed by effects of male gonadal sex and circu-
lating testosterone (indicated by red color in Figure 3).
Finally, a gene co-expression network analysis indicated
overall increased expression connectedness in male net-
works and suggested the presence of a core module of
signal transduction-related genes in all three networks
corresponding to the same male phenotype for each
main factor (Figure 4). These results suggest that the
effect of male sex chromosome complement on lowering
expression of genes related to mood in humans serves to
set up a structure (i.e., gene expression, signaling) that
differs by sex chromosome complement and that is sup-
portive of a ‘disease state,’ as gene changes were often in
pro-disease direction (i.e., ‘indirect’ effect; Figure 5). This
structure is then acted upon by male gonadal sex and
circulating testosterone, which partially opposes the
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expression (i.e., ‘direct’ effect; Figure 5), together creating
a dynamic biological equilibrium regulating gene expres-
sion (i.e., the structure) and adult anxiety-like behaviors
(i.e., the function) (Figure 5). Notably, although circulat-
ing testosterone only partially reverses the effect of male
sex chromosome complement on expression of genes
related to mood regulation in humans, we previously
reported that at the behavioral level, circulating testoster-
one more than compensated for the increased anxiety-like
behavior caused by male sex chromosome complement
[13] (Figure 5), consistent with normal males having lower
anxiety-like behaviors than females. The surprising effect
of sex chromosome complement on expression of GABA-,
serotonin-, and dopamine-related genes establishes this as
a critical and significant contributor to expression of
mouse genes related to mood regulation in humans and
associated sexual dimorphism.Sex chromosome complement as a contributing factor
As apparent in Figure 3, sex chromosome complement
was the factor that exhibited the highest proportion of
main effects on GABA-, serotonin-, and dopamine-related
gene expression. Notably, all significant effects of sex
chromosome complement were in the same direction,
with XY− mice having lower gene expression compared to
XX mice. Our current findings are consistent with a pro-
posed hypothesis regarding sex chromosome complement
and gene expression [57]. It has also been suggested that
X inactivation may result in a large heterochromatic sink
in XX cells that could influence epigenetic processes on all
chromosomes [58]. If the cell has a limited supply of epi-
genetic machinery, and much of this machinery is being
used to inactivating an X, these XX cells would have a
lower supply available for autosomal gene regulation, the
end result being XX cells having globally higher expression
of genes sensitive to heterochromatizing factors (for
example, genes near heterochromatic regions or under
epigenetic regulation). There are several additional mecha-
nisms that could underlie effects of sex chromosome
complement on gene expression. Structurally, sex chro-
mosomes differ between males and females in the
presence of a Y chromosome in males, dosage of X chro-
mosomes, and presence of a paternal X imprint in females
only. Additional sex chromosome complement differences
arise during development; for instance, X inactivation
occurs only in females, and due to random X inactivation,
female tissues are mosaics, with about half of cells
expressing an active maternal X and the other half ex-
pressing an active paternal X. It has also been reported
that some X chromosome genes in females escape X-
inactivation; however, the number of X-escapees is low in
mice (approximately 3%) [59,60].Interaction of gonadal sex and circulating testosterone
Here, we found that expression of a number of genes
varied based on gonadal sex by circulating testosterone
interactions. Although not true for all significant interac-
tions, most followed a similar pattern, with testosterone
treatment causing a decrease in gene expression only in
gonadal males (Figures 1B and 2B). These results sup-
port the well-established concept that the organizational
effects of gonadal hormones during development create
differences in how the adult brain responds to testoster-
one (e.g., [30]; reviewed in [34]). These results also
strengthen the important fact that gonadal males and
females respond differently to adult hormone levels, in-
dicating that hormone treatments in humans may yield
different results in men and women.
How can these results inform risk for psychopathology
in humans?
GABA-related genes
XY−mice, regardless of gonadal sex or circulating hormones,
exhibited reduced expression of genes coding for markers of
dendritic-targeting GABA interneurons (Sst,Vip,Calb1) and
for GABA-synthesizing enzymes (Gad67/65) (Figure 1A;
[13]). Interestingly, XY− mice also displayed elevated
anxiety-like behaviors compared to XX animals [13]. These
molecular findings partly mimic changes observed in hu-
man subjects affected with MDD (see the ‘Background’ sec-
tion and [8,10-12]), supporting the interpretation of a
causal/contributing role of reduced dendritic-targeting
interneuron-mediated inhibition to the respective behav-
ioral phenotypes. Notably, the results that we report here
for Calb1 (XY− <XX, testosterone-treated < blank-treated)
are consistent with previous reports for Calb1 gene expres-
sion in the frontal cortex of FCG mice (XY− <XX, effect of
estrogen receptor alpha signaling [61,62]). A previous study
from our group found reduced TRKB expression in the
sgACC of postmortem brains of patients with MDD [11],
which is consistent with our current finding of reduced
Trkb (Figure 1A) and increased anxiety-like behavior in
XY− mice and negative correlation of Trkb with anxiety-
like behavior.
Serotonin/dopamine-related genes
Htr1a controls serotonin presynaptic release and con-
tributes to postsynaptic signaling, and reduced or lack of
expression is associated with increased anxiety-like be-
haviors [63,64]. Htr2a/2c have been consistently associ-
ated with mood-related phenotypes and are targeted
for the development of therapeutic compounds [65].
Accordingly, reduced Htra1 and Htr2c expressions in
XY mice are consistent with the increased depressive-
like behaviors observed in that group [13] and together
suggests a sexual dimorphism aspect to the low sero-
tonin hypothesis of depression [1]. Not consistent with
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positively correlated with anxiety-like behavior in XY mice
and gonadal males. However, our finding that Htr2c expres-
sion was negatively correlated with anxiety-like behavior
overall and in gonadal females is consistent with these pre-
vious reports (Table 3). A previous study reported that
Adcy5 knockout mice have poor stress coping responses
[66], a finding that is consistent with our current finding
that chronically stressed XY− mice have lower Adcy5 gene
expression (Figure 2A) and increased anxiety-like behavior
compared to XX mice [13]. Interestingly, we also found a
negative correlation of Adcy5 with anxiety-like behavior
(Table 3). Here, we also report that XY− mice have lower
expression of Adcy7 compared to XX mice (Figure 2A) and
a negative correlation between Adcy7 expression and
anxiety-like behavior in gonadal females. This result is not
consistent with reports that decreased Adcy7 results in de-
creased depressive-like behavior [67] and with previous
finding of elevated ADCY7 in the brains of MDD subjects
[68], suggesting that the decreased Adcy7 in our XY− mice
does not underlie their elevated anxiety-like behavior. We
found that Akt1 was reduced in XY− mice but only when
treated in adulthood with testosterone (Figure 2B). Interest-
ingly, one report found reduced AKT1 activity in the brains
of depressed suicide victims [69]. In our correlational ana-
lysis, there were a number of genes that were negatively
correlated in gonadal females, but positively correlated in
gonadal males; this suggests that gonadal males and females
may respond differently to differences in expression of
these genes or that additional factors moderate these be-
haviors (e.g., protein expression or independent factors).
Together, these findings of reduced GABA-, serotonin-,
and dopamine-related gene expression in XY− mice show
that sex chromosome complement plays a role in pro-
gramming expression of these systems to be lower in indi-
viduals with male sex chromosome complement (often in
pro-disease direction). This result is surprising, as women
are more vulnerable to mood disorders, and suggests that
other factors (gonadal sex or circulating testosterone) in
normal males may compensate for the sex chromosome
complement effect on gene expression. Even though our
results did not clearly identify this factor, the heatmap
results show partial, non-significant compensation by a
number of genes due to male gonadal sex and testosterone
(Figure 3). Of note, our previous study in these same FCG
mice found that circulating testosterone potently de-
creased anxiety-like behaviors [13]; thus, future studies
will aim to identify genes and proteins whose expression is
altered in anti-disease directions by circulating testoster-
one treatment.
Limitations
Although the FCG mice provide a valuable tool for
parsing the relative contributions of sex chromosomecomplement, gonadal sex, and circulating hormone to
sexual dimorphism, there are limitations to this model
that must be considered. First, XY− mice are not identi-
cal to wild-type XY mice as the Y chromosome of XY−
mice lacks the Sry gene, but note that when Sry is added
back to XY− mice on an autosome, these XY−Sry male
mice are fertile and display no differences from wild-
type testosterone levels [36,37,70]. Second, normal gene
expression could be disrupted after autosomal Sry trans-
gene insertion. Third, it has been suggested that XY−
females stop cycling early. Our design precludes this
possibility from having an impact, however, since all
mice were gonadectomized 10 weeks prior to sacrifice
and gene expression analysis. Fourth, in addition to its
developmental role in gonad differentiation, Sry is also
expressed in the adult mouse brain [71]; thus, it is not
possible to distinguish indirect effects of Sry in gonad
differentiation (i.e., organizational) from direct effect
based on adult Sry gene expression in FCG mice. Other
potential limitations to the design of this study are that
we do not have a group of mice that was gonadecto-
mized with estradiol and progesterone replacement and
we do not examine gene expression under baseline (i.e.,
non-stress) conditions. Evidence suggests that testoster-
one reduces anxiety-like behaviors [72-75]; on the other
hand, estradiol exposure has been reported to both in-
crease and decrease anxiety-like behavior [76-78]. We
chose to perform testosterone rather than estradiol
replacement based on the more consistent reported re-
sults for testosterone on anxiety-like behavior [72-75].
The study design employed here (baseline behavior test-
ing, followed by 8 weeks of chronic stress and stress-
induced behavior testing, and sacrifice) was employed
due to our interest in identifying genes that may vary by
sex in the context of chronic stress exposure. Based on
this design, however, we are unable to discern whether
effects that we see are due to chronic stress since we did
not examine gene expression under non-stressed condi-
tions. This design was partially dictated by experimental
constraints on the number of mice that can reasonably
be used in a behavior/chronic stress study. Future stud-
ies will examine gene expression in FCG mice under
non-stress conditions and will compare mice gonadecto-
mized and implanted with blank or estradiol-filled cap-
sules. Finally, we investigated only selected genes within
the respective pathways. Large-scale expression analyses
are needed to assess the full extent of the impact of the
respective factors.
Conclusions
These studies provide evidence for a robust effect of XY sex
chromosome complement to decrease expression of genes
related to fast inhibitory GABA signaling and neuromodu-
latory serotonin and dopamine signaling. Combined with
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haviors in XY mice, (2) evidence for involvement of these
systems in the pathology of mood disorders, and (3) con-
cordant directions of gene changes, these results provide
molecular leads to investigate the biological bases of the
sexual dimorphism observed in mood disorders and specif-
ically identify male XY sex chromosome complement as a
pro-disease factor.
Additional files
Additional file 1: Figure S1. Effects of sex-related factors on anxiety-like
emotionality Z-scores. Numbers at the base of bars indicate N. ***p < 0.001,
**p < 0.01; T testosterone, B blank, F gonadal female, M gonadal male.
Additional file 2: Figure S2. Effects of sex-related factors on expression
of GABA-related genes with all eight experimental groups represented
separately. Numbers at the base of bars indicate N. ***p< 0.001, **p< 0.01,
*p< 0.05, #p< 0.1; T testosterone, B blank, F gonadal female, M gonadal male.
Additional file 3: Figure S3. Effects of sex-related factors on expression
of serotonin- and dopamine-related genes with all eight experimental
groups represented separately. Numbers at the base of bars indicate
N. ***p < 0.001, **p < 0.01, *p < 0.05, #p < 0.1; T testosterone, B blank,
F gonadal female, M gonadal male.
Additional file 4: Table S1. Statistical values associated with Pearson
correlation analysis of GABA-related genes versus anxiety-like behavior.
Numbers in bold indicate comparisons that were significant at 5% false
discovery rate with correction for the 14 genes examined.
Additional file 5: Table S2. Statistical values associated with Pearson
correlation analysis of serotonin/dopamine-related genes versus anxiety-like
behavior. Numbers in bold indicate comparisons that were significant at 5%
false discovery rate with correction for the 14 genes examined.
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